Pfizer Osake

Pfizer Termiini P/E

Forward P/E -suhde yhtiöstä Pfizer (PFE) 12.8.2026 päivämäärällä on 20,18. Edellisenä vuonna Forward P/E -suhde oli 19,55 — muutos 3,22 % (korkeampi).

Termiini P/E

20,18

YoY

3,22%

Viimeksi päivitetty:

Forward P/E -suhde yhtiöstä Pfizer on 2026 20,18 . Forward P/E -suhde yhtiöstä Pfizer oli 2025 19,55 . Se laskee 3,22% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Pfizer Osakeanalyysi

Mitä Pfizer tekee? Pfizer Inc, one of the world's largest and most well-known pharmaceutical companies, has made significant advancements in the medical industry throughout its approximately 170-year history. The company is headquartered in New York City and has offices in over 150 countries. Pfizer was founded in 1849 by two cousins, Charles Pfizer and Charles Erhart, who opened their first factory in Brooklyn to produce pure crystalline chinasalt. They later expanded their business and began synthesizing chemical compounds, leading them to enter the pharmaceutical industry. In the following years, Pfizer made some significant discoveries, including the synthesis of antibiotics such as penicillin and terramycin. In the 1990s, the company expanded its portfolio and became a leading provider of prescription drugs, immunological medications, and animal health products. Today, the company focuses on three core areas: innovative health products, patented medications, and generic products. Pfizer invests millions of dollars in research and development of new and innovative treatment options, including cancer drugs, therapies for neurological disorders, cardiovascular diseases, and immunology products. Another important aspect of Pfizer's business model is its partnerships with other companies and organizations. The company works closely with universities, research institutions, governments, and other companies to form partnerships that allow for collaborative development of new products. Some of Pfizer's most well-known products include Viagra, Lipitor, Celebrex, Zoloft, and Lyrica. Viagra is used to treat erectile dysfunction in men. Lipitor is a cholesterol-lowering medication that reduces the risk of cardiovascular diseases. Celebrex is an anti-inflammatory medication used to treat pain and inflammation. Zoloft is an antidepressant used to treat various mental disorders. Lyrica is a prescription medication used to treat pain and seizures. In recent years, Pfizer has also taken a leading role in the development of vaccines against COVID-19, collaborating with the German company BioNTech to develop a promising vaccine candidate. The vaccine provides protection against the virus, particularly against severe illness. Over the years, the company has faced concerns regarding the use of medications, such as the scandal surrounding the pain reliever Vioxx, which was withdrawn in 2004 after being associated with an increased risk of cardiovascular diseases. Pfizer has since strengthened its research and development standards and partnerships to ensure the safety and efficacy of its products. In summary, Pfizer is a global player in the pharmaceutical industry. The company heavily invests in research and development of new products to provide innovative treatment options, secures patents, and simultaneously keeps its portfolio up-to-date with generic products to remain competitive in the industry. The company will continue to contribute to improving healthcare worldwide by developing lifesaving medications and vaccines that enable people to lead better lives. Pfizer on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Pfizer osakkeesta

Yhtiön Pfizer Forward P/E -suhde on 20,18 vuonna 2026.

Forward P/E -suhde yhtiöstä Pfizer muuttui arvosta 19,55 arvoon 20,18, mikä edustaa 3,22 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää Forward P/E -suhde Pfizer:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

Forward P/E käyttää arvioituja tulevia voittoja osakkeen arvostukseen. Pienempi forward P/E peräkkäiseen P/E:hen verrattuna viittaa analyytikkojen odottavan tuloksen kasvua.

Arvioidakseen Forward P/E -suhde:n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja Forward P/E -suhde:lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata Forward P/E -suhde:n Pfizer alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Pfizer

Kaikki tunnusluvut — Pfizer